Egypt
December 2006
This report offers companies, investors, policymakers, and stakeholders crucial insight into the largest pharmaceutical manufacturing base and the second largest pharmaceuticals market by value in the Middle East. Despite recent political upheaval, Egypt is a key growth market with massive unmet needs and huge potential for potential investors.The report features a foreword from President Abdel Fattah El-Sisi, as well as an in-depth interview with Minister of Health Ahmed Emad El Din Rady. It also includes interview with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors.
This report offers companies, investors, policymakers, and stakeholders crucial insight into the largest pharmaceutical manufacturing base and the second largest pharmaceuticals market by value in the Middle East. Despite recent political upheaval, Egypt is a key growth market with massive unmet needs and huge potential for potential investors.The report features a foreword from President Abdel Fattah El-Sisi, as well as an in-depth interview with Minister of Health Ahmed Emad El Din Rady. It also includes interview with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors.
Key Market Facts
- Egypt's pharmaceutical market was valued at approximately EGP 25-30 billion ($3-3.5 billion at 2015 exchange rates) in 2015, with a government-controlled pricing system keeping medicine prices among the lowest in the Middle East.
- EIPICO, Pharco Pharmaceuticals, Amoun Pharmaceutical, Eva Pharma, and Memphis Chemical are among Egypt's leading domestic manufacturers, with the local industry producing approximately 90% of pharmaceutical needs by volume.
- Regulatory authority: CAPA (Central Administration of Pharmaceutical Affairs) under the Ministry of Health oversaw pharmaceutical regulation and drug registration in Egypt in 2015, with ongoing modernisation of the regulatory framework.
- Egypt's domestic pharmaceutical manufacturing sector is one of Africa's most developed, producing the vast majority of the country's pharmaceutical needs locally and exporting to other African and Middle Eastern markets.
- Egypt's pharmaceutical market in 2015 faced the challenge of government-fixed drug prices that had not kept pace with inflation and currency weakness, creating margin pressure for domestic manufacturers and barriers to innovative medicine market entry.
Sharing Link
or sharing via
